These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11306524)

  • 1. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women.
    Koh KK; Jin DK; Yang SH; Lee SK; Hwang HY; Kang MH; Kim W; Kim DS; Choi IS; Shin EK
    Circulation; 2001 Apr; 103(15):1961-6. PubMed ID: 11306524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women.
    Koh KK; Ahn JY; Jin DK; Yoon BK; Kim HS; Kim DS; Shin MS; Son JW; Choi IS; Shin EK
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1459-64. PubMed ID: 12231566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2002 Mar; 105(12):1436-9. PubMed ID: 11914251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women.
    Barrett-Connor E; Slone S; Greendale G; Kritz-Silverstein D; Espeland M; Johnson SR; Waclawiw M; Fineberg SE
    Maturitas; 1997 Jul; 27(3):261-74. PubMed ID: 9288699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial.
    Hu P; Greendale GA; Palla SL; Reboussin BA; Herrington DM; Barrett-Connor E; Reuben DB
    Atherosclerosis; 2006 Apr; 185(2):347-52. PubMed ID: 16023653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular effects of estrogen in type II diabetic postmenopausal women.
    Koh KK; Kang MH; Jin DK; Lee SK; Ahn JY; Hwang HY; Yang SH; Kim DS; Ahn TH; Shin EK
    J Am Coll Cardiol; 2001 Nov; 38(5):1409-15. PubMed ID: 11691516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
    JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of estrogen and micronized progesterone or medroxyprogesterone acetate on cognition in postmenopausal women.
    Sherwin BB; Grigorova M
    Fertil Steril; 2011 Aug; 96(2):399-403. PubMed ID: 21703613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormone therapy and change in mammographic density.
    Greendale GA; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Ursin G
    J Natl Cancer Inst; 2003 Jan; 95(1):30-7. PubMed ID: 12509398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women.
    Koh KK; Cardillo C; Bui MN; Hathaway L; Csako G; Waclawiw MA; Panza JA; Cannon RO
    Circulation; 1999 Jan; 99(3):354-60. PubMed ID: 9918521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of low-dose medroxyprogesterone acetate and oral estrogen does not affect endothelial function in the forearms of postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Nagai N; Chayama K; Ohama K
    Menopause; 2002; 9(5):360-6. PubMed ID: 12218725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of conventional or lower doses of hormone replacement therapy in postmenopausal women.
    Koh KK; Shin MS; Sakuma I; Ahn JY; Jin DK; Kim HS; Kim DS; Han SH; Chung WJ; Shin EK
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1516-21. PubMed ID: 15166013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tibolone and conventional hormone replacement therapies on arterial and hepatic cholesterol accumulation and on circulating endothelin-1, vascular cell adhesion molecule-1, and E-selectin in surgically menopausal monkeys.
    Register TC; Wagner JD; Zhang L; Hall J; Clarkson TB
    Menopause; 2002; 9(6):411-21. PubMed ID: 12439100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
    Taner MZ; Ozpolat E; Taskiran C; Onan MA; Gursel T; Karabulut E; Gursoy R; Himmetoglu O
    Maturitas; 2006 Feb; 53(3):267-73. PubMed ID: 15978753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of estrogen and vitamin E therapies in postmenopausal women.
    Koh KK; Blum A; Hathaway L; Mincemoyer R; Csako G; Waclawiw MA; Panza JA; Cannon RO
    Circulation; 1999 Nov; 100(18):1851-7. PubMed ID: 10545428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women.
    Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):571-6. PubMed ID: 14699021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.